021-51111890
购物车（）
sales@molnova.cn
PF-04895162
CAS No. ——
PF-04895162 ( ICA-105665 | PF 04895162 | ICA105665 | PF 4895162 )
产品货号. M16958 CAS No. ——
PF-04895162 (ICA-105665, PF 4895162) 是一种口服的神经元 Kv7 钾通道激动剂，可打开 Kv7.2/7.3 和 Kv7.3/7.5 钾通道。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PF-04895162
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述PF-04895162 (ICA-105665, PF 4895162) 是一种口服的神经元 Kv7 钾通道激动剂，可打开 Kv7.2/7.3 和 Kv7.3/7.5 钾通道。
-
产品描述PF-04895162 (ICA-105665, PF 4895162) is an orally available agonist of neuronal Kv7 potassium channel, opens Kv7.2/7.3 and Kv7.3/7.5 potassium channels, also known as KCNQ2/3 and KCNQ3/5 channels; ICA-105665 has demonstrated broad spectrum antiseizure activity in multiple animal models including maximal electroshock, 6 Hz seizures, pentylenetetrazole, and electrical kindling at doses from <1 to 5 mg/kg.Epilepsy Phase 1 Discontinued.
-
体外实验——
-
体内实验——
-
同义词ICA-105665 | PF 04895162 | ICA105665 | PF 4895162
-
通路Cell Cycle/DNA Damage
-
靶点Potassium Channel
-
受体Potassium Channel
-
研究领域——
-
适应症——
化学信息
-
CAS Number——
-
分子量355.345
-
分子式C19H15F2N3O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称N-(2-cyclopropyl-7-fluoro-4-oxoquinazolin-3(4H)-yl)-2-(4-fluorophenyl)ethanamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Kasteleijn-Nolst Trenité DG, et al. Epilepsia. 2013 Aug;54(8):1437-43.
2. Aleo MD, et al. Pharmacol Res Perspect. 2019 Feb;7(1):e00467.
3. Bialer M, et al. Epilepsy Res. 2013 Jan;103(1):2-30.
4. Roeloffs R, et al. J Pharmacol Exp Ther. 2008 Sep;326(3):818-28.
产品手册
关联产品
-
ASP 2905
一种新型有效、选择性、口服生物可利用的电压门控钾通道 KCNH3 抑制剂，IC50 为 9.0 nM。
-
Rabeprazole
Rabeprazole (LY307640) 是一种二代质子泵抑制剂 (pump inhibitor, PPI)，不可逆地抑制胃 H+/K+-ATPase。Rabeprazole 诱导细胞凋亡 (apoptosis)。Rabeprazole 也抑制尿苷核苷核糖水解酶 (UNH) ，IC50 为 0.3 μM。Rabeprazole 可用于胃溃疡和胃食管反流的研究。
-
Iberiotoxin
Selective blocker of the big conductance Ca2+-activated K+ channel.
